Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Minoxidil 1 mg in Female Patients With Androgenetic Alopecia
NCT05888922Phase 3Active, not recruiting
- Sponsor
- Cantabria Labs
- Start
- Oct 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by Cantabria Labs. Started Oct 2024; status: active, not recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT05888922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05888922.